MATH values were higher in the BLCA cases with TP53 mutations than in those with FGFR3-mutant (Fig. 5a, p < 0.001) or no TP53- and FGFR3-mutant (Fig. 5a, p < 0.001) group. This evidence concerns the gene TP53 and bladder transitional cell carcinoma.